About FDA
Cumulative number of convictions at the end of the quarter
Dictionary: Cumulative number of OCI criminal convictions, where an individual has plead guilty or been declared guilty by a qualified court for violation of the Food, Drug & Cosmetic Act (FDCA).
Information is current as of February 12, 2013.
Fiscal Year - 2012
| Time | Target | Number of Convictions |
|---|---|---|
| Oct – Dec 2011 | N/A | 65 |
| Jan – Mar 2012 | N/A | 129 |
| Apr – Jun 2012 | N/A | 194 |
| Jul – Sep 2012 | N/A | 262 |
FY 2012 Total: 262
Cumulative amount of money recovered through OCI actions at the end of the quarter
Dictionary: Cumulative monies collected through fines and restitutions imposed by the U.S. Courts for criminal acts enforced under the Food, Drug & Cosmetic Act (FDCA).
Fiscal Year - 2012
| Time | Target | Dollars Recovered |
|---|---|---|
| Oct – Dec 2011 | N/A | 719.28 |
| Jan – Mar 2012 | N/A | 750.03 |
| Apr – Jun 2012 | N/A | 1,078.60 |
| Jul – Sep 2012 | N/A | 4,952.81 |
FY 2012 Total: $4,952,811,090
Footnotes
- Dollars recovered are reported in millions
Number of U.S. Attorney press releases issued relative to OCI investigative activities during the month
Dictionary: Number of U.S. Attorney press releases issued during the reporting period related to OCI criminal investigations (i.e. arrests, convictions and sentencing). Link to OCI press releases.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 9 |
| Nov 2011 | N/A | 8 |
| Dec 2011 | N/A | 9 |
| Jan 2012 | N/A | 4 |
| Feb 2012 | N/A | 8 |
| Mar 2012 | N/A | 11 |
| Apr 2012 | N/A | 9 |
| May 2012 | N/A | 14 |
| Jun 2012 | N/A | 5 |
| Jul 2012 | N/A | 5 |
| Aug 2012 | N/A | 6 |
| Sep 2012 | N/A | 8 |
FY 2012 Total: 96
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
